Investigators analyzed economic evaluations of adjuvant immunotherapy to assess cost-effectiveness outcomes, quality-adjusted life-year (QALY)/life-year (LY) gains, and methodologic approaches.

Please provide your email address to receive an email when new articles are posted on . High-cost immunotherapy was associated with increased likelihood of being unable to afford medical care and ...

Surgery was found to be slightly more cost-effective than radiotherapy for treating esophageal squamous cell carcinoma (ESCC) in China, according to a study published January 30 in Springer Nature.

The Free Press Journal: Anant Madabhushi, the F. Alex Nason Professor II of Biomedical Engineering and director of the Center for Computational Imaging and Personalized Diagnostics, the high cost of ...

Immunotherapy given before or after surgery is increasingly used across several cancer areas. In an article published in the Journal of Internal ...

A study published today in the Journal of Cancer Survivorship found that cancer survivors receiving high-cost immunotherapy treatments were more likely to face financial hardship, leading to increased ...